|
Volumn 75, Issue 20, 2001, Pages 9644-9653
|
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ADEFOVIR;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
LAMIVUDINE;
NEVIRAPINE;
NUCLEOSIDE;
P6 PROTEIN;
PROTEINASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
UNCLASSIFIED DRUG;
VIRUS ENZYME;
VIRUS PROTEIN;
ZALCITABINE;
ZIDOVUDINE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CONTROLLED STUDY;
GENE MUTATION;
GENE TARGETING;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR CLONING;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN PROCESSING;
VIRUS INFECTIVITY;
AMINO ACID SEQUENCE;
ANTI-HIV AGENTS;
BASE SEQUENCE;
CLONING, MOLECULAR;
DRUG RESISTANCE, MICROBIAL;
GENE PRODUCTS, GAG;
GENES, VIRAL;
HIV INFECTIONS;
HIV-1;
HUMANS;
MOLECULAR SEQUENCE DATA;
MUTAGENESIS, SITE-DIRECTED;
POLYMORPHISM, GENETIC;
PROLINE;
REVERSE TRANSCRIPTASE INHIBITORS;
VIRAL PROTEINS;
|
EID: 0034812843
PISSN: 0022538X
EISSN: None
Source Type: Journal
DOI: 10.1128/JVI.75.20.9644-9653.2001 Document Type: Article |
Times cited : (71)
|
References (35)
|